Advanced Imaging Technology InfraReDx's innovative Makoto Intravascular Imaging System, combined with their Dualpro IVUS+NIRS catheter, offers high-precision diagnostics for coronary artery disease, presenting opportunities to target high-end cardiology centers and hospitals seeking cutting-edge diagnostic tools.

Strategic Market Expansion The recent launch of the Makoto system and Dualpro catheter in Japan indicates readiness for international expansion. Sales efforts could focus on global markets with high cardiovascular disease prevalence, especially in regions with growing interventional cardiology practices.

Strong Industry Collaborations Partnerships with major players like B. Braun Interventional Systems bolster InfraReDx’s market credibility and acceptance. This creates opportunities for joint ventures and partnership-driven sales channels within hospital and device distributor networks.

Robust Funding and Growth Potential With a funding of $25 million and revenue estimates between $10 million to $25 million, InfraReDx demonstrates growth capacity. Targeting clinical trial collaborations and evidence-based marketing can accelerate adoption among healthcare providers focused on improved patient outcomes.

Technology-Driven Differentiators InfraReDx's focus on identifying plaque risk and reducing adverse cardiac events positions their products as essential for cardiology departments aiming for precision medicine. Emphasizing these benefits can enhance pitch strategies to hospital procurement teams seeking advanced, minimally invasive diagnostics.